)
EMVision Medical Devices (EMV) investor relations material
EMVision Medical Devices H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Developed portable neurodiagnostic devices for acute neurological emergencies, targeting stroke and traumatic brain injury markets with multi-billion-dollar potential and unmet needs in acute care and rural health.
Over $60 million invested in R&D, with strong clinical data, global partnerships, and significant grant agreements, including a $3M CRC-P grant for regional stroke care studies.
Six pivotal clinical studies underway, including collaborations with leading stroke centers, ambulance services, and regional partners.
Strong balance sheet with $17.5 million cash, $7.0 million in secured grants, and $3.8 million R&D rebate expected.
Loss after tax for the half-year was $3,967,663, up from $3,571,869 year-over-year, mainly due to higher non-cash share-based payment expenses.
Financial highlights
Net loss after tax for 1H26 was $3.97 million, compared to $3.57 million loss in 1H25, with net loss per share at 4.45 cents.
Total non-dilutive grant income and R&D tax incentive income reached $3.8 million for the half.
Cash and cash equivalents at period end were $17,545,236, up from $10,456,814 at June 2025, following a $14 million capital raise.
Total expenses rose to $8,014,381 (from $6,883,300), driven by R&D, employee, and share-based payment costs.
Net assets increased to $19,741,470 from $9,282,964 at June 2025.
Outlook and guidance
Targeted completion of pivotal trial enrolment and readout in 1H26, with FDA De Novo submission planned.
Multiple clinical studies progressing, including aeromedical, mobile stroke unit, and road ambulance studies.
Anticipates further grant receipts contingent on milestone achievements, including $4M from the Industry Growth Program and $2.6M from CRC-P through 2028.
Expects to receive a $3.8M R&D Tax Incentive rebate in Q1 2026.
Commercial launch focused on the US 'Stroke Belt' region, with plans for national and international expansion.
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage